South Georgia Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CS
South Georgia Capital's IBB Position: Q3 2015 in Review
South Georgia Capital reduced its iShares Biotechnology ETF (IBB) stake by 98% in Q3 2015, selling an estimated $1.84M and leaving 300 shares worth $30K. The position accounts for 0.07% of the portfolio, ranked #73.
South Georgia Capital first reported a position in IBB in Q1 2015 and has held it in 3 quarters since. The position peaked at $1.92M in Q2 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q3 2015.
- South Georgia Capital held 300 shares of iShares Biotechnology ETF worth $30K as of Q3 2015.
- South Georgia Capital sold 15,300 iShares Biotechnology ETF shares in Q3 2015, an estimated $1.84M.
- iShares Biotechnology ETF made up 0.07% of South Georgia Capital's portfolio in Q3 2015, its #73 holding.
- South Georgia Capital first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 3 quarters since.
- South Georgia Capital's iShares Biotechnology ETF position peaked at $1.92M in Q2 2015.
- 415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2015.
Based on South Georgia Capital's 13F filing for Q3 2015, filed 10 Nov 2015.